Diabetic eye screening: optical coherence tomography in surveillance
Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.
- From:
-
- Published
- 8 July 2020
- Last updated
-
16
27AprilSeptember20252024— See all updates
Applies to England
Documents
Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics
Ref: PHE publications gateway number GW-1385
HTML
Diabetic eye screening: OCT in surveillance pathway
Ref: PHE publications gateway number GW-1385
HTML
Details
This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).
This publication was previously published by Public Health England, which closed on 30 September 2021.
Updates to this page
Published 8 July 2020
Last updated 1627 AprilSeptember 2025
+ show hide all updates" href="#full-history">+ show all updates
-
-
Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.
-
-
-
10 July 2024
Removed PHE
-
-
10 July 2024
Updated guidance
-
-
8 July 2020
First published.
Sign up for emails or print this page
Update history
2025-04-16 14:54
Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.
2024-09-27 16:23
Added clarification that publication was previously published by Public Health England.
2024-07-10 15:26
Removed PHE
2024-07-10 15:24
Updated guidance
Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics
Ref: PHE publications gateway number GW-1385
HTML
Diabetic eye screening: OCT in surveillance pathway
Ref: PHE publications gateway number GW-1385
HTML
Details
This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).
This publication was previously published by Public Health England, which closed on 30 September 2021.
Updates to this page
Last updated 16
-
Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.
-
10 July 2024 Removed PHE
-
10 July 2024 Updated guidance
-
8 July 2020 First published.
Sign up for emails or print this page
Update history
2025-04-16 14:54
Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.
2024-09-27 16:23
Added clarification that publication was previously published by Public Health England.
2024-07-10 15:26
Removed PHE
2024-07-10 15:24
Updated guidance